CLINICAL_TRIALS
trial_result
· 2017-10-19
Clinical Trial Update: A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis [Phase 3]
Summary
Phase 3 clinical trial update for guselkumab in moderate to severe plaque-type psoriasis completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2017-10-19